Angela R. McLean

6.1k citations

52 papers · 4.7k indexed · 2 hit papers · h-index 33

Virology top 0.2%
Immunology top 1%
Infectious Diseases top 1%
Molecular Biology top 10%
Public Health, Environmental and Occupational Health top 2%

Co-authors: Roy M. Anderson Sally Blower Robert M. May Martin A. Nowak Colin Michie C. J. Alcock Peter C. L. Beverley Henrique Veiga‐Fernandes
Topics: HIV Research and Treatment (21 papers)Prion Diseases and Protein Misfolding (12 papers)HIV/AIDS Research and Interventions (12 papers)
Cited by: Virology Modeling and Simulation Immunology
Journals: Nature Science Proceedings of the National Academy of Sciences
Partner nations: United Kingdom United States France

In The Last Decade

Angela R. McLean

52 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lifespan of human lymphocyte subsets defined by CD45 isoforms

1992 534 citations Colin Michie, Angela R. McLean et al. Nature profile →
Persistent HIV-1 replication maintains the tissue reservoir during therapy

2016 458 citations Ramón Lorenzo-Redondo, Helen Fryer et al. Nature profile →

Peers

Countries citing papers authored by Angela R. McLean

Since Specialization

Citations

This map shows the geographic impact of Angela R. McLean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela R. McLean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela R. McLean more than expected).

Fields of papers citing papers by Angela R. McLean

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela R. McLean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela R. McLean. The network helps show where Angela R. McLean may publish in the future.

Co-authorship network of co-authors of Angela R. McLean

This figure shows the co-authorship network connecting the top 25 collaborators of Angela R. McLean. A scholar is included among the top collaborators of Angela R. McLean based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela R. McLean. Angela R. McLean is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mapping social distancing measures to the reproduction number for COVID-19 2021 ·Philosophical Transactions of the Royal Society B Biological Sciences ·Ellen Brooks‐Pollock,Jonathan M. Read,Angela R. McLean,Matt J. Keeling,León Danon	21
2	Persistent HIV-1 replication maintains the tissue reservoir during therapybreakdown → 2016 ·Nature ·Ramón Lorenzo-Redondo,Helen Fryer,Trevor Bedford,Eun‐Young Kim,John Archer,Sergei L. Kosakovsky Pond,Yoon‐Seok Chung,Sudhir Penugonda,Jeffrey G. Chipman,Courtney V. Fletcher,Timothy W. Schacker,Michael H. Malim,Andrew Rambaut,Ashley T. Haase,Angela R. McLean,Steven M. Wolinsky	458
3	Seven challenges in modeling pathogen dynamics within-host and across scales 2014 ·Epidemics ·Julia R. Gog,Lorenzo Pellis,James L. N. Wood,Angela R. McLean,Nimalan Arinaminpathy,James O. Lloyd‐Smith	63
4	Modelling the Spread of HIV Immune Escape Mutants in a Vaccinated Population 2011 ·PLoS Computational Biology ·Helen Fryer,Angela R. McLean	7
5	Modelling the Evolution and Spread of HIV Immune Escape Mutants 2010 ·PLoS Pathogens ·Helen Fryer,John Frater,Anna Duda,M. G. Roberts,(unknown),Rodney E. Phillips,Angela R. McLean	46
6	Inefficient Cytotoxic T Lymphocyte–Mediated Killing of HIV-1–Infected Cells In Vivo 2006 ·PLoS Biology ·Becca Asquith,Charles T. T. Edwards,Marc Lipsitch,Angela R. McLean	124
7	A scrapie epidemic in Cyprus 2004 ·Epidemiology and Infection ·Mike B. Gravenor,(unknown),Angela R. McLean,(unknown)	14
8	Modelling the national scrapie eradication programme in the UK 2001 ·Mathematical Biosciences ·Rowland R. Kao,Mike B. Gravenor,Angela R. McLean	31
9	Scrapie in Britain during the BSE years 2000 ·Nature ·Mike B. Gravenor,David R. Cox,Linda Hoinville,(unknown),Angela R. McLean	18
10	Response of naïve and memory CD8+ T cells to antigen stimulation in vivo 2000 ·Nature Immunology ·Henrique Veiga‐Fernandes,Ulrich Walter,Christine Bourgeois,Angela R. McLean,Bénédita Rocha	446
11	AIDS: Decline and fall of immune surveillance? 1997 ·Current Biology ·Mark B. Feinberg,Angela R. McLean	25
12	Modelling HIV vaccination 1995 ·Trends in Microbiology ·Angela R. McLean,Sally Blower	40
13	The intrinsic transmission dynamics of tuberculosis epidemics 1995 ·Nature Medicine ·Sally Blower,Angela R. McLean,Travis C. Porco,Peter M. Small,Philip C. Hopewell,Melissa Sanchez,Andrew R. Moss	354
14	Models of interactions between HIV and other pathogens 1992 ·Journal of Theoretical Biology ·Angela R. McLean,Martin A. Nowak	63
15	Competition between zidovudine-sensitive and zidovudine-resistant strains of HIV 1992 ·AIDS ·Angela R. McLean,Martin A. Nowak	102
16	Lifespan of human lymphocyte subsets defined by CD45 isoformsbreakdown → 1992 ·Nature ·Colin Michie,Angela R. McLean,C. J. Alcock,Peter C. L. Beverley	534
17	Population dynamics of HIV within an individual after treatment with zidovudine 1991 ·AIDS ·Angela R. McLean,Vincent C. Emery,Alison Webster,Paul Griffiths	64
18	A model of human immunodeficiency virus infection in T helper cell clones 1990 ·Journal of Theoretical Biology ·Angela R. McLean,Tbl Kirkwood	35
19	Possible demographic consequences of AIDS in developing countries 1988 ·Nature ·Roy M. Anderson,Robert M. May,Angela R. McLean	121
20	Measles in developing countries. Part II. The predicted impact of mass vaccination 1988 ·Epidemiology and Infection ·Angela R. McLean,Roy M. Anderson	135

About Angela R. McLean

Angela R. McLean is a scholar working on Virology, Modeling and Simulation and Agronomy and Crop Science, having authored 52 papers that have together received 4.7k indexed citations. Recurring topics across this work include HIV Research and Treatment (21 papers), Prion Diseases and Protein Misfolding (12 papers) and HIV/AIDS Research and Interventions (12 papers). The work is most often cited by research in Virology (1.7k citations), Modeling and Simulation (534 citations) and Immunology (1.6k citations). Angela R. McLean has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Roy M. Anderson, Sally Blower, Robert M. May, Martin A. Nowak, Colin Michie, C. J. Alcock, Peter C. L. Beverley, Henrique Veiga‐Fernandes, Bénédita Rocha and Ulrich Walter. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact